Analysis of viral diversity in relation to the recency of HIV-1C infection in Botswana

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Moyo, Sikhulile ^a,b   Vandormael, Alain ^c   Wilkinson, Eduan ^c   Engelbrecht, Susan ^a,d   Gaseitsiwe, Simani ^b,e   Kotokwe, Kenanao P ^b   Musonda, Rosemary ^b,e   Tanser, Frank ^c   Essex, Max ^b,e   Novitsky, Vladimir ^b,e   De Oliveira, Tulio ^c,f,g  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; BOTSWANA; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN C); HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MICROBIAL DIVERSITY; MICROBIOLOGICAL PARAMETERS; MULTIPLICITY OF INFECTION; PAIRWISE DISTANCE; SCREENING; SEROLOGIC INCIDENCE; VIRUS GENOME; ADULT; BLOOD; FEMALE; GENETIC VARIATION; GENETICS; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; PATHOGENICITY; VIROLOGY;

BIOLOGICAL MARKER; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; BIOMARKERS; BOTSWANA; FEMALE; GENETIC VARIATION; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 84984848340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160649     Document Type: Article

References (90)

1. Brenner BG, Roger M, Routy J-P, Moisi D, Ntemgwa M, Matte C, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007; 195(7):951-9. PMID: 17330784
2. Pilcher CD, Eron JJ Jr, Galvin S, Gay C, Cohen MS. Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest. 2004; 113(7):937-45. PMID: 15057296.
3. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med. 2003; 9(7):847-52. PMID: 12835704
4. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005; 191 (9):1403-9. PMID: 15809897.
5. Gray GE, Andersen-Nissen E, Grunenberg N, Huang Y, Roux S, Laher F, et al. HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults. AIDS Res Hum Retroviruses. 2014; 30 Suppl 1:A33-4. Epub 2014/10/31. doi: 10.1089/aid.2014.5052a.abstract PMID: 25357829.
6. Lima KO, Salustiano DM, Cavalcanti AM, Leal Ede S, Lacerda HR. HIV-1 incidence among people seeking voluntary counseling and testing centers, including pregnant women, in Pernambuco State, Northeast Brazil. Cad Saude Publica. 2015; 31(6):1327-31. Epub 2015/07/23. doi: 10.1590/0102-311x00186813 PMID: 26200379.
7. Lu X, Kang X, Chen S, Zhao H, Liu Y, Zhao C, et al. HIV-1 genetic diversity and transmitted drug resistance among recently infected individuals at MSM sentinel surveillance points in Hebei province, China. AIDS Res Hum Retroviruses. 2015. Epub 2015/07/23. doi: 10.1089/aid.2015.0160 PMID: 26200883.
8. Lunar MM, Matkovic I, Tomazic J, Vovko TD, Pecavar B, Poljak M. Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm. J Med Virol. 2015; 87 (9):1510-6. Epub 2015/05/15. doi: 10.1002/jmv.24209 PMID: 25970253.
9. Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, et al. Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV. 2015; 2(7):e279-e87. Epub 2015/07/15. doi: 10.1016/s2352-3018(15)00058-2 PMID: 26155597; PubMed Central PMCID: PMCPMC4491329.
10. Kassanjee R, McWalter TA, Barnighausen T, Welte A. A New General Biomarker-based Incidence Estimator. Epidemiology. 2012. Epub 2012/05/26. doi: 10.1097/EDE.0b013e3182576c07 PMID: 22627902.
11. Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, Merks H, Vallée D, Caminiti K, et al. Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis. 2012:jis411.
12. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol. 2013; 177(3):264-72. Epub 2013/01/11. doi: 10.1093/aje/kws436 PMID: 23302151; PubMed Central PMCID: PMC3626051.
13. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, et al. HIV Diversity as a Biomarker for HIV Incidence Estimation: Including a High Resolution Melting Diversity Assay in a Multi-Assay Algorithm. J Clin Microbiol. 2013. Epub 2013/10/25. doi: 10.1128/JCM.02040-13 PMID: 24153134.
14. Emerson B, Plough K. Detection of acute HIV-1 infections utilizing NAAT technology in Dallas, Texas. J Clin Virol. 2013; 58 Suppl 1:e48-53. Epub 2013/09/04. doi: 10.1016/j.jcv.2013.08.005 PMID: 23999031.
15. Barnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell M. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS. 2008; 22(1):139-44. doi: 10.1097/QAD.0b013e3282f2ef43 PMID: 18090402
16. Kim JH, Excler JL, Michael NL. Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection. Annu Rev Med. 2014. Epub 2014/10/24. doi: 10.1146/annurevmed-052912-123749 PMID: 25341006.
17. Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, et al. HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis. 2006; 33(11):646-51. doi: 10.1097/01. olq.0000223283.27142.9f PMID: 16773032
18. Tanser F, Bärnighausen T, Vandormael A, Dobra A. HIV treatment cascade in migrants and mobile populations. Current Opinion in HIV and AIDS. 2015; 10(6):430-8. doi: 10.1097/COH. 0000000000000192 PMID: 26352396
19. Visser MJ, Makin JD, Vandormael A, Sikkema KJ, Forsyth BW. HIV/AIDS stigma in a South African community. AIDS care. 2009; 21(2):197-206. doi: 10.1080/09540120801932157 PMID: 19229689
20. Vandormael A, Newell M-L, Bärnighausen T, Tanser F. Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study. The Lancet Global Health. 2014; 2(4):e209-e15. PMID: 24782953
21. Barnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell ML. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS. 2008; 22(1):139-44. Epub 2007/12/20. doi: 10.1097/QAD.0b013e3282f2ef43 PMID: 18090402.
22. Novitsky V, Woldegabriel E, Wester C, McDonald E, Rossenkhan R, Ketunuti M, et al. Identification of primary HIV-1C infection in Botswana. AIDS Care. 2008; 20(7):806-11. Epub 2008/07/09. doi: 10.1080/09540120701694055 PMID: 18608056; PubMed Central PMCID: PMCPmc2605733.
23. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, et al. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008; 3(4):e1954. Epub 2008/04/17. doi: 10.1371/journal.pone.0001954 PMID: 18414658; PubMed Central PMCID: PMCPmc2278382.
24. Dandona L, Kumar G, Lakshmi V, Ahmed GM, Akbar M, Ramgopal S, et al. HIV incidence from the first population-based cohort study in India. BMC Infect Dis. 2013; 13(1):327. doi: 10.1186/1471-2334-13-327
25. Dandona L, Lakshmi V, Sudha T, Kumar G, Dandona R. A population-based study of human immunodeficiency virus in south India reveals major differences from sentinel surveillance-based estimates. BMC Med. 2006; 4:31. doi: 10.1186/1741-7015-4-31 PMID: 17166257
26. Feldblum P, Latka M, Lombaard J, Chetty C, L Chen P, Sexton C, et al. HIV incidence and prevalence among cohorts of women with higher risk behaviour in Bloemfontein and Rustenburg, South Africa: a prospective study. BMJ Open. 2012; 2(1):e000626. doi: 10.1136/bmjopen-2011-000626 PMID: 22331388
27. Geis S, Maboko L, Saathoff E, Hoffmann O, Geldmacher C, Mmbando D, et al. Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania. J Acquir Immune Defic Syndr. 2011; 56(5):453-9. doi: 10.1097/QAI.0b013e3182118fa3 PMID: 21297483
28. Lopman B, Nyamukapa C, Mushati P, Mupambireyi Z, Mason P, Garnett G, et al. HIV incidence in 3 years of follow-up of a Zimbabwe cohort-1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol. 2008; 37(1):88-105. doi: 10.1093/ije/dym255 PMID: 18203774
29. Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, et al. Workshop summary: Novel biomarkers for HIV incidence assay development. AIDS Res Hum Retroviruses. 2012; 28(6):532-9. Epub 2011/12/31. doi: 10.1089/aid.2011.0332 PMID: 22206265; PubMed Central PMCID: PMC3358102.
30. Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y, Meyer L, et al. Principles and uses of HIV incidence estimation from recent infection testing - a review. Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2008; 13(36):537-45.
31. Hallett TB. Estimating the HIV incidence rate: recent and future developments. Curr Opin HIV AIDS. 2011; 6(2):102-7. Epub 2011/04/21. doi: 10.1097/COH.0b013e328343bfdb PMID: 21505383; PubMed Central PMCID: PMC3083833.
32. Rosenberg NE, Pilcher CD, Busch MP, Cohen MS. How can we better identify early HIV infections? Curr Opin HIV AIDS. 2014. Epub 2014/11/13. doi: 10.1097/coh.0000000000000121 PMID: 25389806.
33. Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014; 28 (16):2439-49. doi: 10.1097/QAD.0000000000000429 PMID: 25144218; PubMed Central PMCID: PMC4210690.
34. Duong YT, Kassanjee R, Welte A, Morgan M, De A, Dobbs T, et al. Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes. PLoS One. 2015; 10(2):e0114947. Epub 2015/02/25. doi: 10.1371/journal.pone.0114947 PMID: 25710171.
35. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012; 7(3):e33328. doi: 10.1371/journal.pone.0033328 PMID: 22479384
36. Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, et al. Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses. 2015; 7(10):5508-24. doi: 10.3390/v7102887 PMID: 26512688
37. Andersson E, Shao W, Bontell I, Cham F, Cuong DD, Wondwossen A, et al. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infect, Genet Evol. 2013; 18:125-31.
38. Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, et al. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical infectious diseases. 2011:ciq164.
39. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, et al. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS ONE. 2011; 6(11):e27211. Epub 2011/11/11. doi: 10.1371/journal.pone. 0027211 PMID: 22073290; PubMed Central PMCID: PMC3206918.
40. Allam O, Samarani S, Ahmad A. Hammering out HIV-1 incidence with Hamming distance. AIDS. 2011; 25(16):2047-8. doi: 10.1097/QAD.0b013e32834bac66 PMID: 21997490
41. Hall N. Advanced sequencing technologies and their wider impact in microbiology. J Exp Biol. 2007; 210(Pt 9):1518-25. Epub 2007/04/24. doi: 10.1242/jeb.001370 PMID: 17449817.
42. Joseph SB, Swanstrom R, Kashuba AD, Cohen MS. Bottlenecks in HIV-1 transmission: insights from the study of founder viruses. Nat Rev Microbiol. 2015. Epub 2015/06/09. doi: 10.1038/nrmicro3471 PMID: 26052661.
43. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences. 2008; 105(21):7552-7. doi: 10.1073/pnas.0802203105
44. Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, Lee F-H, et al. Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5. J Virol. 2013; 87(5):2401-11. doi: 10.1128/jvi.02964-12 PMID: 23269796
45. Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF, et al. Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin a4β7. PLoS Pathog. 2012; 8(5):e1002686. doi: 10.1371/journal.ppat. 1002686 PMID: 22693444
46. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999; 73(12):10489-502. Epub 1999/11/13. PMID: 10559367; PubMed Central PMCID: PMCPMC113104.
47. Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, et al. Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. Virology. 2009; 383(1):47-59. doi: 10.1016/j. virol.2008.09.017 PMID: 18973914
48. Kearney M, Maldarelli F, Shao W, Margolick JB, Daar ES, Mellors JW, et al. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol. 2009; 83(6):2715-27. Epub 2009/01/01. doi: 10.1128/jvi.01960-08 PMID: 19116249; PubMed Central PMCID: PMCPmc2648286.
49. Giorgi E, Funkhouser B, Athreya G, Perelson A, Korber B, Bhattacharya T. Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics. 2010; 11 (1):532. doi: 10.1186/1471-2105-11-532
50. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing. J Virol. 2008; 82(8):3952-70. doi: 10.1128/jvi.02660-07 PMID: 18256145
51. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol. 2009; 83(8):3556-67. Epub 2009/02/06. JVI.02132-08 [pii] doi: 10.1128/JVI.02132-08 PMID: 19193811.
52. Novitsky V, Wang R, Margolin L, Baca J, Rossenkhan R, Moyo S, et al. Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection. PLoS One. 2011; 6(2):e16714. PMCID: PMC3048432. Epub 2011/03/19. doi: 10.1371/journal.pone.0016714 PMID: 21415914.
53. Kiwelu IE, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, et al. HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies. PLoS One. 2012; 7(10):e47605. PMCID: PMC3485255. doi: 10.1371/journal.pone.0047605 PMID: 23118882; PubMed Central PMCID: PMC3485255.
54. Redd AD, Mullis CE, Serwadda D, Kong X, Martens C, Ricklefs SM, et al. The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis. 2012; 206 (2):267-74. doi: 10.1093/infdis/jis325 PMID: 22675216; PubMed Central PMCID: PMC3415936.
55. Redd AD, Mullis CE, Wendel SK, Sheward D, Martens C, Bruno D, et al. Limited HIV-1 superinfection in seroconverters from the CAPRISA 004 Microbicide Trial. J Clin Microbiol. 2014; 52(3):844-8. doi: 10.1128/JCM.03143-13 PMID: 24371237; PubMed Central PMCID: PMC3957790.
56. Novitsky V, Wang R, Margolin L, Baca J, Moyo S, Musonda R, et al. Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. Virology. 2010; 403(1):37-46. Epub 2010/05/07. S0042-6822(10)00236-9 [pii] doi: 10.1016/j.virol.2010.04.001 PMID: 20444482.
57. Novitsky V, Wang R, Kebaabetswe L, Greenwald J, Rossenkhan R, Moyo S, et al. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. J Acquir Immune Defic Syndr. 2009; 52(2):265-72. Epub 2009/06/16. doi: 10.1097/QAI.0b013e3181ab6ef0 PMID: 19525854.
58. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr. 2003; 33(3):349-55. PMID: 12843746.
59. Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, et al. Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. Journal of acquired immune deficiency syndromes (1999). 2009; 50(1):65.
60. Novitsky V, Woldegabriel E, Wester C, McDonald E, Rossenkhan R, Ketunuti M, et al. Identification of primary HIV-1C infection in Botswana. NIHMSID # 79283. AIDS Care. 2008; 20(7):806-11. PMID: 18608056. doi: 10.1080/09540120701694055
61. Park SY, Goeken N, Lee HJ, Bolan R, Dube MP, Lee HY. Developing high-throughput HIV incidence assay with pyrosequencing platform. J Virol. 2014; 88(5):2977-90. doi: 10.1128/JVI.03128-13 PMID: 24371062; PubMed Central PMCID: PMC3958066.
62. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, et al. Significantly diminished longterm specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010; 53(4):496-9. Epub 2010/03/23. PMID: 20306555.
63. Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M. Intra-Host Evolutionary Rates in HIV-1C env and gag during Primary Infection. Infect Genet Evol. 2013;s1567-1348(13):77-4. Epub 2013/03/26. doi: 10.1016/j.meegid.2013.02.023 PMID: 23523818.
64. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003; 17(13):1871-9. PMID: 12960819.
65. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004; 5:113. PMID: 15318951.
66. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30(12):2725-9. doi: 10.1093/molbev/mst197 PMID: 24132122; PubMed Central PMCID: PMC3840312.
67. Price MN, Dehal PS, Arkin AP. FastTree 2-Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE. 2010; 5(3):e9490. doi: 10.1371/journal.pone.0009490 PMID: 20224823
68. Rambaut A. FigTree; http://tree.bio.ed.ac.uk/software/figtree/. 1.1.2 ed2008.
69. Fawcett T. An introduction to ROC analysis. Pattern Recog Lett. 2006; 27(8):861-74.
70. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol. 2004; 42(6):2623-8. PMID: 15184443.
71. Huber PJ, editor The behavior of maximum likelihood estimation under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability; 1967: University of California Press.
72. White H. Maximum likelihood estimation of misspecied models. Econometrica. 1982; 50:1-25.
73. Shaw PA, Pepe MS, Alonzo TA, Etzioni R. Methods for assessing improvement in specificity when a biomarker is combined with a standard screening test. Statistics in biopharmaceutical research. 2009; 1(1):18-25. PMID: 20054437
74. Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, et al. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013; 8(12):e82772. Epub 2014/01/05. doi: 10.1371/journal.pone.0082772 PMID: 24386116; PubMed Central PMCID: PMCPMC3873916.
75. Yu L, Laeyendecker O, Wendel SK, Liang F, Liu W, Wang X, et al. Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China. AIDS Res Hum Retroviruses. 2015; 31(12):1247-9. Epub 2015/09/04. doi: 10.1089/aid.2015. 0097 PMID: 26331573; PubMed Central PMCID: PMCPmc4663635.
76. Janes H, Longton G, Pepe M. Accommodating covariates in ROC analysis. The Stata Journal. 2009; 9 (1):17. PMID: 20046933
77. Pepe M, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. The Stata journal. 2009; 9(1):1. PMID: 20161343
78. UNAIDS. WHO/UNAIDS Technical Update on HIV incidence assays for surveillance and epidemic monitoring. Geneva, Swtizerland: UNAIDS; 2013. Available: http://www.unaids.org/en/resources/documents/2015/HIVincidenceassayssurveillancemonitoring.
79. Guy R, Gold J, Calleja JMG, Kim AA, Parekh B, Busch M, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. The Lancet infectious diseases. 2009; 9(12):747-59. doi: 10.1016/S1473-3099(09)70300-7 PMID: 19926035
80. Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 2011; 8(6):e1001045. Epub 2011/07/07. doi: 10.1371/journal.pmed.1001045 PMID: 21731474; PubMed Central PMCID: PMC3114871.
81. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. Estimating HIV Incidence among Adults in Kenya and Uganda: A Systematic Comparison of Multiple Methods. PLoS ONE. 2011; 6(3): e17535. Epub 2011/03/17. doi: 10.1371/journal.pone.0017535 PMID: 21408182; PubMed Central PMCID: PMC3049787.
82. Xia X-Y, Ge M, Hsi JH, He X, Ruan Y-H, Wang Z-X, et al. High-Accuracy Identification of Incident HIV-1 Infections Using a Sequence Clustering Based Diversity Measure. PLoS ONE. 2014; 9(6):e100081. doi: 10.1371/journal.pone.0100081 PMID: 24925130
83. Chaillon A, Le Vu S, Brunet S, Gras G, Bastides F, Bernard L, et al. Decreased Specificity of an Assay for Recent Infection in HIV-1-Infected Patients on Highly Active Antiretroviral Treatment: Implications for Incidence Estimates. Clinical and Vaccine Immunology: CVI. 2012; 19(8):1248-53. doi: 10.1128/CVI.00120-12 PMC3416072. PMID: 22718132
84. Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, et al. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One. 2014; 9 (6):e101043. Epub 2014/06/27. doi: 10.1371/journal.pone.0101043 PMID: 24968135; PubMed Central PMCID: PMCPmc4072769.
85. Moyo S, LeCuyer T, Wang R, Gaseitsiwe S, Weng J, Musonda R, et al. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. AIDS Res Hum Retroviruses. 2014; 30(1):29-36. Epub 2013/08/14. doi: 10.1089/AID.2013.0055 PMID: 23937344; PubMed Central PMCID: PMC3887420.
86. Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. Aids. 2014; 28 (16):2439-49. Epub 2014/08/22. doi: 10.1097/qad.0000000000000429 PMID: 25144218.
87. Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, et al. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nat Med. 2015; 21 (10):1139-41. Epub 2015/09/01. doi: 10.1038/nm.3932 PMID: 26322580; PubMed Central PMCID: PMCPMC4598284.
88. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog. 2010; 6(5):e1000890. Epub 2010/05/21. doi: 10.1371/journal.ppat. 1000890 PMID: 20485520.
89. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, Grayson T, et al. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol. 2010; 84(12):6241-7. Epub 2010/04/09. JVI.00077-10 [pii] doi: 10.1128/JVI.00077-10 PMID: 20375173.
90. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008; 13(36). Epub 2008/09/09. PMID: 18775293.